Novo Nordisk and HFA Collaboration: Hopeful Future for Hemophilia B
Hemophilia Federation of America (HFA) shared a reminder post on X:
”Time is running out to register!
Join us tomorrow, July 29 ,at 7pm ET for Living with Hemophilia B: From Challenges to Hopeful Futures, an interactive virtual event presented in partnership with Novo Nordisk.”
Register now.
In collaboration with Novo Nordisk, the Hemophilia Federation of America (HFA) will host a virtual presentation on July 29 at 7 p.m. EST, led by Dr. Robert Sidonio.
This interactive session will explore the everyday challenges faced by individuals living with hemophilia B and provide a platform for open dialogue around personal experiences, treatment roadblocks, and future hopes for disease management.
With a focus on community engagement and patient-centered care, the event aims to foster shared understanding and highlight evolving needs in hemophilia B care.
Do not miss any conference or webinar on hemophilia management, read Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia